articles

Auto Added by WPeMatico

GO1, an enterprise learning platform, picks up $40M from Microsoft, Salesforce and more

Published May 18, 2020

With a large proportion of knowledge workers doing now doing their jobs from home, the need for tools to help them feel connected to their profession can be as important as tools to, more practically, keep them connected. Today, a company that helps do precisely that is announcing a growth round of funding after seeing engagement on its platform triple in the last month.

GO1.com, an online learning platform focused specifically on professional training courses (both those to enhance a worker’s skills as well as those needed for company compliance training), is today announcing that it has raised $40 million in funding, a Series C that it plans to use to continue expanding its business. The startup was founded in Brisbane, Australia and now has operations also based out of San Francisco — it was part of a Y Combinator cohort back in 2015 — and more specifically, it wants to continue growth in North America, and to continue expanding its partner network.

GO1 not disclosing its valuation but we are asking. It’s worth pointing out that not only has it seen engagement triple in the last month as companies turn to online learning to keep users connected to their professional lives even as they work among children and house pets, noisy neighbours, dirty laundry, sourdough starters, and the rest (and that’s before you count the harrowing health news we are hit with on a regular basis). But even beyond that, longer term GO1 has shown some strong signs that speak of its traction.

It counts the likes of the University of Oxford, Suzuki, Asahi and Thrifty among its 3,000+ customers, with more than 1.5 million users overall able to access over 170,000 courses and other resources provided by some 100 vetted content partners. Overall usage has grown five-fold over the last 12 months. (GO1 works both with in-house learning management systems or provides its own.)

“GO1’s growth over the last couple of months has been unprecedented and the use of online tools for training is now undergoing a structural shift,” said Andrew Barnes, CEO of GO1, in a statement. “It is gratifying to fill an important void right now as workers embrace online solutions. We are inspired about the future that we are building as we expand our platform with new mediums that reach millions of people every day with the content they need.”

The funding is coming from a very strong list of backers: it’s being co-led by Madrona Venture Group and SEEK — the online recruitment and course directory company that has backed a number of edtech startups, including FutureLearn and Coursera — with participation also from Microsoft’s venture arm M12; new backer Salesforce Ventures, the investing arm of the CRM giant; and another previous backer, Our Innovation Fund.

Microsoft is a strategic backer: GO1 integrated with Teams, so now users can access GO1 content directly via Microsoft’s enterprise-facing video and messaging platform.

“GO1 has been critical for business continuity as organizations navigate the remote realities of COVID-19,” said Nagraj Kashyap, Microsoft Corporate Vice President and Global Head of M12, in a statement. “The GO1 integration with Microsoft Teams offers a seamless learning experience at a time when 75 million people are using the application daily. We’re proud to invest in a solution helping keep employees learning and businesses growing through this time.”

Similarly, Salesforce is also coming in as a strategic, integrating this into its own online personal development products and initiatives.

“We are excited about partnering with GO1 as it looks to scale its online content hub globally. While the majority of corporate learning is done in person today, we believe the new digital imperative will see an acceleration in the shift to online learning tools. We believe GO1 fits well into the Trailhead ecosystem and our vision of creating the life-long learner journey,” said Rob Keith, Head of Australia, Salesforce Ventures, in a statement.

Working remotely has raised a whole new set of challenges for organizations, especially those whose employees typically have never before worked for days, weeks and months outside of the office.

Some of these have been challenges of a more basic IT nature: getting secure access to systems on the right kinds of machines and making sure people can communicate in the ways that they need to to get work done.

But others are more nuanced and long-term but actually just as important, such as making sure people remain in a healthy state of mind about work. Education is one way of getting them on the right track: professional development is not only useful for the person to do her or his job better, but it’s a way to motivate people, to focus their minds, and take a rest from their routines, but in a way that still remains relevant to work.

GO1 is absolutely not the only company pursuing this opportunity. Others include Udemy and Coursera, which have both come to enterprise after initially focusing more on traditional education plays. And LinkedIn Learning (which used to be known as Lynda, before LinkedIn acquired it and shifted the branding) was a trailblazer in this space.

For these, enterprise training sits in a different strategic place to GO1, which started out with compliance training and onboarding of employees before gravitating into a much wider set of topics that range from photography and design, through to Java, accounting, and even yoga and mindfulness training and everything in between.

It’s perhaps the directional approach, alongside its success, that have set GO1 apart from the competition and that has attracted the investment, which seems to have come ahead even of the current boost in usage.

“We met GO1 many months before COVID-19 was on the tip of everyone’s tongue and were impressed then with the growth of the platform and the ability of the team to expand their corporate training offering significantly in North America and Europe,” commented S. Somasegar, managing director, Madrona Venture Group, in a statement. “The global pandemic has only increased the need to both provide training and retraining – and also to do it remotely. GO1 is an important link in the chain of recovery.” As part of the funding Somasegar will join the GO1 board of directors.

Notably, GO1 is currently making all COVID-19 related learning resources available for free “to help teams continue to perform and feel supported during this time of disruption and change,” the company said.

Give the gift of Extra Crunch membership

Published May 14, 2020

Starting today, TechCrunch readers can send an Extra Crunch annual membership as a gift to a friend, family member or co-worker. For a limited time we’re offering the gift at a discounted rate of $99/year (plus tax).

The gifting feature can be found here.

Extra Crunch membership is designed for startup teams, entrepreneurs, investors and business school students, and it includes more than 100 exclusive articles per month:

Find out where startup investors plan to write their next checks in our weekly surveys
Build your company better with how-tos and interviews from experts on fundraising, growth, monetization and other key work topics
Learn about the best startups today through our IPO analysis, late-stage deep dives and other exclusive reporting delivered daily

Extra Crunch membership can save you time time with an exclusive newsletter, no banner ads, Rapid Read mode and our List Builder tool. Annual and two-year members can also save money with discounts on events and access to Partner Perks. Our Partner Perks provide discounted access to services from companies like AWS, Brex, DocSend, Crunchbase, Typeform and more.

Gifting is currently supported in the U.S., Canada, U.K. and select countries in Europe. Purchases can be made through Visa, Mastercard and PayPal in all supported countries, but Amex support is limited to the U.S. and Canada.

If there are other features you’d like to see us add to Extra Crunch, please let us know by leaving a comment on this post or emailing me directly at travis@techcrunch.com.

TechCrunch readers can find the Extra Crunch gifting feature here.

China’s smartphone shipments are reportedly up for April, following COVID-19-fueled decline

Published May 12, 2020

Smartphone shipments are reportedly beginning to see signs of life in China, after a sizable dip from the COVID-19 pandemic. New numbers from China Academy of Information and Communications Technology (a government-connected agency) point to a 17% rise in shipments for April, pointing to some recovery for the market.

The figure, from the China state-supported group, is virtually a mirror reflection of the 18% dip Canalys reported for Q1. COVID-19 was the primary culprit for those figures, through a combination of decreased spending among China’s phone-buying public and sizable supply chain constraints, as many Asian nations were on lockdown to slow the spread.

Both Huawei and Apple benefited from the rebound, though Reuters notes that the firm opted not to include an OS breakdown for the first time in a while, making it more difficult to parse market share.

Smartphone shipments dropped 18% in China, thanks to COVID-19

Smartphone shipments have suffered across the board, along with countless other industries. A rebound for China’s market could be a bellwether for positive numbers for the industry moving forward — especially given the country’s close ties to the global supply chain. In spite of being the first country hit, China’s official figures for COVID-19 deaths have remained low, compared to countries in Europe and North America.

That’s likely due in part to some draconian measures used to stop the spread. Other countries (the U.S. in particular) may not be so likely to rebound from the pandemic, leading to a more protracted impact on the global market.

3D-printed glasses startup Fitz is making custom protective eyewear for healthcare workers

Published April 20, 2020

A lot of startups have answered the call for more personal protective equipment (PPE) and other essentials to support healthcare workers in their efforts to curb the spread and impact of COVID-19. One of those is direct-to-consumer 3D-printed eyewear brand Fitz, which is employing its custom-fit glasses technology to build protective, prescription specs for front-line healthcare workers in need of the best protection they can get.

Fitz Protect is a version of Fitz’s eyewear that uses the same custom measurement tool Fitz created for use via its iOS app, made possible by Apple’s depth-sensing Face ID camera on newer iPhones and all iPad Pro models. The app allows virtual try-on, and provides millimeter-level accurate measurements for a custom fit. Protect is a version of the glasses that still supports a wide range of prescriptions, but that also extends further like safety glasses to provide more coverage and guard against errant entry of any fluids through the eyes.

Healthcare professionals are doing what they can to ensure their face, mouth, nose and eyes are protected from any coughs, sneezes or other droplet-spreading activity from COVID-19 patients that could pass on the infection. These measures have more broadly focused on face shields that feature a single transparent plastic sheet, and N95 masks (and alternatives when not available) to protect the mouth and nose.

Fitz CEO Gabriel Schlumberger explained via email that the design for Fitz Protect came from working front-line doctors and nurses from New York, LA and Texas who were all looking for something to source prescription protective eyewear.

“More than 60% of doctors are glasses wearers, and current guidance is for them to stop wearing contact lenses,” Schlumberger explained, adding that Fitz Protect is also designed to be worn in conjunction with a face shield, when that’s an available option, to provide yet another layer of defense.

“We heard from prescription glasses wearers that their standard glasses didn’t provide anywhere near adequate coverage, especially over the eyebrows, and in some cases they were adding cardboard cut-outs,” he said. “We leveraged our existing system to create something much better. ”

Fitz’s model also helps on the pricing side because it’s already designed to be an aggressively cost-competitive offering when compared to traditional prescription eyewear. Their glasses typically retail for just $95 including frames, lenses and shipping, and are also offered in a $185 per year unlimited frame membership plan. For doctors, nurses and hospital staff, the entire cost of Fitz Protect is being waived, and the company is seeking donations to help offset its own manufacturing costs, which currently stand at around $100 per set, though process improvements should bring that down, according to Schlumberger, as they expand availability.

Already, he said that nearly 3,000 healthcare professionals have signed up to receive a pair in their first week of availability, so they’re working on adding scale to keep up with the unexpected demand.

YC startup Felix wants to replace antibiotics with programmable viruses

Published March 21, 2020

Right now the world is at war. But this is no ordinary war. It’s a fight with an organism so small we can only detect it through use of a microscope — and if we don’t stop it, it could kill millions of us in the next several decades. No, I’m not talking about COVID-19, though that organism is the one on everyone’s mind right now. I’m talking about antibiotic-resistant bacteria.

You see, more than 700,000 people died globally from bacterial infections last year — 35,000 of them in the U.S. If we do nothing, that number could grow to 10 million annually by 2050, according to a United Nations report.

The problem? Antibiotic overuse at the doctor’s office or in livestock and farming practices. We used a lot of drugs over time to kill off all the bad bacteria — but it only killed off most, not all, of the bad bacteria. And, as the famous line from Jeff Goldblum in Jurassic Park goes, “life finds a way.”

Enter Felix, a biotech startup in the latest Y Combinator batch that thinks it has a novel approach to keeping bacterial infections at bay – viruses.

Phage killing bacteria in a petri dish

It seems weird in a time of widespread concern over the corona virus to be looking at any virus in a good light but as co-founder Robert McBride explains it, Felix’s key technology allows him to target his virus to specific sites on bacteria. This not only kills off the bad bacteria but can also halt its ability to evolve and once more become resistant.

But the idea to use a virus to kill off bacteria is not necessarily new. Bacteriophages, or viruses that can “infect” bacteria, were first discovered by an English researcher in 1915 and commercialized phage therapy began in the U.S. in the 1940’s through Eli Lilly and Company. Right about then antibiotics came along and Western scientists just never seemed to explore the therapy further.

However, with too few new solutions being offered and the standard drug model not working effectively to combat the situation, McBride believes his company can put phage therapy back at the forefront.

Already Felix has tested its solution on an initial group of 10 people to demonstrate its approach.

Felix researcher helping cystic fibrosis patient Ella Balasa through phage therapy

“We can develop therapies in less time and for less money than traditional antibiotics because we are targeting orphan indications and we already know our therapy can work in humans,” McBride told TechCrunch . “We argue that our approach, which re-sensitizes bacteria to traditional antibiotics could be a first line therapy.”

Felix plans to deploy its treatment in those suffering from cystic fibrosis first as there is no cure for this disease, which tends to require a near constant stream of antibiotics to combat lung infections.

The next step will be to conduct a small clinical trial involving 30 people, then, as the scientific research and development model tends to go, a larger human trial before seeking FDA approval. But McBride hopes his viral solution will prove itself out in time to help the coming onslaught of antibiotic resistance.

“We know the antibiotic resistant challenge is large now and is only going to get worse,” McBride said. “We have an elegant technological solution to this challenge and we know our treatment can work. We want to contribute to a future in which these infections do not kill more than 10 million people a year, a future we can get excited about.”

Scanwell aims to launch at-home 15-minute coronavirus test, but it still needs FDA approval

Published March 20, 2020

At-home diagnostics startup Scanwell, which produces smartphone-based testing for UTIs, is working on getting at-home testing for the novel coronavirus into the hands of U.S. residents. The technology, which was developed by Chinese diagnostic technology company INNOVITA and has already been approved by China’s equivalent of the FDA and used by “millions” in China, can be taken at home in 15 minutes with the guidance of a medical professional via telehealth, and produces results in just hours.

Scanwell’s test will require FDA clearance, but the company tells me that it’s in the process of securing approval through the FDA’s accelerated emergency certification program. The FDA guidance says that this approval process should take 6-8 weeks (though that “could be faster,” Scanwell says), and Scanwell is aiming to be ready to go with shipping these as soon as it receives that approval. While the U.S. drug regulatory agency previously had only included PCR tests in its protocols, it updated that guidance to include serological tests earlier this week. Scanwell further says they “don’t anticipate any issues with FDA approval.”

The test that Scanwell is aiming to launch uses what’s called a ‘serological’ technique, which looks for antibodies in a patient’s blood. These are only present if someone has been exposed to the SARS-CoV-2 virus, since as of right now researchers haven’t found any evidence that natural antibodies to this particular virus exist without exposure. By contrast, the types of tests that are currently in use in the U.S. are “PCR” tests, which use a molecular-based approach to determine if the virus is present genetically in a mucus sample.

The PCR type of test is technically more accurate than the serological variety, but the serological version is much easier to administer, and produces results more quickly. It’s also still very accurate on the whole, and is much cheaper to produce than the PCR version. Plus, it could help expand efforts beyond testing only the most severe cases with symptoms present, and do a much better job of illuminating the full extent of the presence of the virus, including among people with mild cases who have already recovered at home, and those who are asymptomatic but carrying the virus with the possibility of infecting others.

Also, while other, PCR-based at-home testing options already exist, like one from Everlywell that will start going out on Monday, require round-tripping test samples, adding time, complexity and cost and relying on testing materials like swabs that are in short supply globally.

Once the test is available, people deemed eligible via Scanwell’s screening process in their Scanwell Health app will be sent the test via next-day delivery. They’ll be guided by telehealth partner Lemonaid‘s licensed doctors and nurse practitioners, and they’ll then receive results and further guidance about those results via the app within a few hours. The whole testing process will cost $70, which Scanwell says just covers its costs (it’s also looking at ways to provide free service to those who need it), and will be deployed first in Washington, California and New York, as well as other areas depending on the severity of their coronavirus situation.

That the tests will take potentially 6-8 weeks to come to market seems like a long time, given the current state of the rapidly evolving COVID-19 situation and testing. But we’ll likely still be very much in need of testing options at that time, especially ones that can serve people who aren’t necessarily meeting the criteria for other available testing resources.

YC-backed Giveaway is a peer-to-peer marketplace that uses virtual currency

Published March 12, 2020

YC-backed Giveaway lets folks give away their unused or unnecessary items in a marketplace. Unlike other buy and sell or donation platforms, Giveaway uses a virtual currency on the platform to reward people for listing their products for free on the app.

Users earn Karma coins each time they list an item on the website. Folks can then use that Karma to claim items listed on the app.

The first person to try to claim an item offers zero Karma for the item. From there, a countdown begins, allowing others to offer more Karma for the item until the clock runs out. The user who offered the most Karma gets to claim the item. They are then connected to the giver via the app and can set a time and place to meet for the transaction. The person who claimed the item can inspect it and then approve the transaction, triggering the exchange of Karma coin.

Users can also rate and review each other on the platform for the quality of their items.

The app promotes giving items away to earn Karma but does offer a flow for purchasing the virtual currency. One Karma coin is equal to about $.30.

Giveaway was founded by Artem Artemiuk, Siarhei Lepchankou, and Siarhei Stasilovich. The idea came to them when traveling in Austria and coming across a store that allowed customers to choose one item for free.

After building the platform, the trio launched the app in their home market of Belarus and saw strong early growth. Since then, Giveaway has expanded to Russia, Ukraine, Kazakhstan, and now the United States.

Artemiuk, Giveaway’s CMO, said the company is laser focused on pre-moderation, which uses a combination of machine learning and human input to ensure that inappropriate items don’t make it on the platform, including drugs, tobacco, alcohol, and weapons.

In terms of business model, Giveaway takes a percentage of all Karma coins purchased on the platform, which account for about 30 percent of all Karma. Giveaway also sees the opportunity to generate revenue through an enterprise product within the app, allowing big corporations to opt for Giveaway over sometimes costly recycling options, and pay for the opportunity to do so.

Giveaway has raised $150K from Y Combinator and will present at the accelerator’s upcoming demo day.

Startups Weekly: Oyo has issues + A farewell

Published January 4, 2020

Welcome back to Startups Weekly, a weekend newsletter that dives into the week’s noteworthy startups and venture capital news. Before I jump into today’s topic, let’s catch up a bit. Last week I wrote about the startups we lost in 2019. Before that, I noted the defining moments of VC in 2019.

Unfortunately, this will be my last newsletter, as I am leaving TechCrunch for a new opportunity. Don’t worry, Startups Weekly isn’t going anywhere. We’ll have a new writer taking over the weekly update soon enough; in the meantime, TechCrunch editor Henry Pickavet will be at the helm. You can still get in touch with me on Twitter @KateClarkTweets.

If you’re new here, you can subscribe to Startups Weekly here. Lots of good content will be coming your way in 2020.

India’s WeWork?

TechCrunch reporter Manish Singh penned an interesting piece on the state of Indian startups this week: As Indian startups raise record capital, losses are widening (Extra Crunch membership required). In it, he claims the financial performance of India’s largest startups are cause for concern. Gems like Flipkart, BigBasket and Paytm have lost a collective $3 billion in the last year.

“What is especially troublesome for startups is that there is no clear path for how they would ever generate big profits,” he writes. “Silicon Valley companies, for instance, have entered and expanded into India in recent years, investing billions of dollars in local operations, but yet, India has yet to make any substantial contribution to their bottom lines. If that wasn’t challenging enough, many Indian startups compete directly with Silicon Valley giants, which while impressive, is an expensive endeavor.”

Manish’s story came one day after The New York Times published an in-depth report on Oyo, a tech-enabled budget hotel chain and rising star in the Indian tech community. The NYT wrote that Oyo offers unlicensed rooms and has bribed police officials to deter trouble, among other toxic practices.

Whether Oyo, backed by billions from the SoftBank Vision Fund, will become India’s WeWork is the real cause for concern. India’s startup ecosystem is likely to face a number of barriers as it grows to compete with the likes of Silicon Valley.

Follow Manish here or on Twitter for more of TechCrunch’s growing India coverage.

Venture capital highlights (it’s been a slow week)

How to find the right reporter to pitch your startup

If you’ve still not subscribed to Extra Crunch, now is the time. Longtime TechCrunch reporter and editor Josh Constine is launching a new series to teach you how to pitch your startup. In it he will examine embargoes, exclusives, press kit visuals, interview questions and more. The first of many, How to find the right reporter to pitch your startup, is online now.

Subscribe to Extra Crunch here.

#EquityPod

Another week, another new episode of TechCrunch’s venture capital-focused podcast, Equity. This week, we discussed a few of 2019’s largest scandals, Peloton’s strange holiday ad and the controversy over at the luggage startup Away. Listen here and be sure to subscribe, too.

For anyone wondering about changes at Equity following my departure from TechCrunch, the lovely Alex Wilhelm (founding Equity co-host) will keep the show alive and, soon enough, there will be a brand new co-host in my place. Please keep supporting the show and be sure to recommend it to all your podcast-adoring friends.

Brand power vs. product power

Published December 16, 2019

David Friend
Contributor

David Friend is the CEO of cloud storage company Wasabi, and co-founder of cyber security company Carbonite, recently bought for $1.4 billion. Wasabi is his sixth startup.

Bird’s chief legal & policy officer is leaving the company

Published October 15, 2019

Bird, the $2.5 billion electric scooter business, is losing its chief legal and policy officer. David Estrada, who was hired last year from Kitty Hawk, is joining another mobility company, SoftBank-backed Nuro.

A spokesperson for Bird tells TechCrunch Estrada is leaving the Santa Monica-based company to be closer to his family. Nuro, for its part, is based in Mountain View, CA.

Bird’s former chief legal officer, David Estrada.

Estrada, who previously oversaw public policy at the electric aircraft company Kitty Hawk as its chief legal officer, has been responsible for Bird’s compliance and government relations efforts as the company scaled to over 100 global cities. Prior to joining Kitty Hawk, Estrada spent nearly two years as Lyft’s vice president of government relations and worked as the legal director for Google X, partnering with states on legislation around autonomous vehicles, Google Glass and drone delivery.

How Nuro plans to spend Softbank’s $940 million

Nuro, founded in June 2016, has emerged as a key player in the rapidly-expanding autonomous delivery sector. The company has attracted a whopping $1.03 billion in venture capital funding to date, according to Pitchbook. SoftBank funneled an astounding $940 million into the business earlier this year at an undisclosed valuation. In addition to SoftBank, Nuro is backed by Greylock and the Chinese venture capital firm Gaorong Capital.

The company has been developing a self-driving stack and combining it with a custom unmanned vehicle designed for last-mile delivery of local goods and services. It began piloting grocery delivery in 2018 in the Phoenix suburb of Scottsdale.

Bird has overcome a number of unique hurdles with many more afoot, including pushback from local governments who were aggravated by the sudden appearance of hundreds of scooters. At Nuro, Estrada will have the opportunity to focus on the future of unmanned delivery, another sector faced with regulatory challenges and political barriers.

Bird raises $275 million Series D round at a $2.5 billion valuation